ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Letter to the Editor



Let us discuss the COVID-19 vaccine for children

Sonia Gulia, Kusum K. Rohilla, Mahendra Kumar, Raman Sharma.



Abstract
 Download PDF Post

A large number of COVID-19 vaccinations are now being licensed for use in children, even though the majority of them are exclusively intended for adults (18 years and older). When creating their COVID-19 immunization policies and programs, countries should consider the individual and population benefits of immunizing children and adolescents in their unique epidemiological. Immunizing children and adolescents is less urgent than immunizing older individuals, those with chronic health conditions, and healthcare professionals because they typically have milder disease compared to adults, unless they are in a group at increased risk of severe COVID-19.

Key words: Immunization; COVID-19 vaccine; Children; Adolescents.

Bibliomed Article Statistics

22
21
R
E
A
D
S

21

18
D
O
W
N
L
O
A
D
S
1112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.